Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E Kansu, D Ward, AP Sanchez, R Cunard, M Hayran… - …, 2022 - Taylor & Francis
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …
被引用次数：3 相关文章

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E Kansu, D Ward, AP Sanchez… - Hematology …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E KANSU, D Ward, A Sanchez, R Cunard… - …, 2022 - avesis.hacettepe.edu.tr
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Extracorporeal photopheresis for the treatment of chronic graft versus host disease.

E Kansu, D Ward, AP Sanchez, R Cunard… - Hematology …, 2022 - europepmc.org
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

E KANSU, D Ward, A Sanchez, R Cunard… - …, 2022 - avesis.hacettepe.edu.tr
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause
of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) …